B. Metzler seel. Sohn & Co’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,946
Closed -$285K 768
2022
Q1
$285K Hold
3,946
﹤0.01% 699
2021
Q4
$372K Sell
3,946
-198
-5% -$23.7K ﹤0.01% 613
2021
Q3
$526K Sell
4,144
-996
-19% -$145K 0.01% 550
2021
Q2
$855K Buy
5,140
+463
+10% +$75K 0.01% 463
2021
Q1
$850K Hold
4,677
0.01% 446
2020
Q4
$1.01M Buy
+4,677
New +$951K 0.02% 393

Other funds holding TDOC

B. Metzler seel. Sohn & Co's TDOC Position: Q2 2022 in Review

B. Metzler seel. Sohn & Co sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,946 shares — an estimated $285K sold.

B. Metzler seel. Sohn & Co first reported a position in TDOC in Q4 2020 and held it in 6 quarters. The position peaked at $1.01M in Q4 2020. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • B. Metzler seel. Sohn & Co reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 3,946 Teladoc Health shares in Q2 2022, an estimated $285K.
  • B. Metzler seel. Sohn & Co first reported a position in Teladoc Health in Q4 2020 and held it in 6 quarters.
  • B. Metzler seel. Sohn & Co's Teladoc Health position peaked at $1.01M in Q4 2020.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2022, filed 12 Aug 2022.